Medtronic cuts estimated medical device tax impact in half

February 19, 2013 by MassDevice staff

Medtronic joins fellow medical device giants in forecasting lower 2013 medtech tax costs than previously anticipated.

Medtronic logo

Medical device maker Medtronic (NYSE:MDT) this week became the latest in a string of medtech giants who have pared back their expectations of the impact of the 2.3% medical device sales tax.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.